Stock Market News
Latest financial news · Updated May 24, 2026
Cotton Mostly Weaker on Friday
The cotton market is bearish due to sluggish export demand, with commitments lagging behind USDA forecasts. While crude oil prices …
Homebuying in America: The lending process “was probably the biggest headache”
The panel consensus is bearish on the housing market, with builders' use of captive lending and incentives signaling weakness and …
Soybeans Easing Lower on Friday
The panel is mixed on the soybean market outlook, with concerns about weak export commitments and growing South American supply, …
Corn Fading Back on Friday
The panel is divided on the near-term outlook for corn prices, with some seeing profit-taking and others anticipating a demand …
IWM’s Surge in Unusual Options Activity Signals Opportunity — Here’s a Covered Strangle With a Twist
The panel overwhelmingly agrees that selling a covered strangle on IWM is a high-risk strategy, given the current geopolitical instability, …
AT&T drops 3 new phone plans to keep customers from switching
The consensus is that AT&T's new 'Unlimited Your Way' plans are a defensive move to combat rising postpaid churn and …
Transform Microsoft Stock Weakness Into A $1,700 Payoff With A Butterfly Trade
The panel is divided on MSFT's outlook, with bulls focusing on strong fundamentals and AI growth, while bears warn of …
1 ‘Key’ Stock That’s Up More Than 80% Over the Past Year
The panel consensus is bearish on Keysight Technologies (KEYS) due to its extreme valuation, decelerating revenue growth, and significant risks …
Are Fertilizers a Compelling Opportunity?
The panel agrees on a near-term supply shock in the fertilizer market due to potential disruptions in the Strait of …
Hyperliquid’s S&P 500 market quickly hits $100m in just one day. Here’s what to expect next
The panel generally agrees that Hyperliquid's $100m S&P 500 volume signals genuine demand for 24/7 trading of traditional assets on …
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
The panel consensus is bearish on RTW's investment in APLS, with key concerns being the thin margins, regulatory risks, and …
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
The panel is divided on Cogent Biosciences (COGT) with concerns about label risk, competition from Blueprint Medicines' Ayvakit, and potential …